Department of Radiology, Shanghai Jiao Tong University, Shanghai, China.
J Gastroenterol Hepatol. 2010 Mar;25(3):499-505. doi: 10.1111/j.1440-1746.2009.06107.x. Epub 2010 Jan 13.
To retrospectively analyze and compare the clinical efficacy of temporary stent insertion with pneumatic dilation of the same diameter in the treatment of achalasia based on a long-term follow up.
A total of 101 treated achalasia patients were divided into a pneumatic dilation group (Group A, n = 38) and a temporary stent insertion group (Group B, n = 63). The diameter of the balloon or stent used was 30 mm. The total symptom scores (TSS) and esophageal manometry were used to assess the symptoms and lower esophageal sphincter (LES) pressure improvement. Barium swallow-esophageal studies were used to assess esophageal emptying objectively. TSS and LES pressure improvement were assessed, recorded, and compared during the regular interval follow up.
Forty-nine pneumatic dilations and 65 stent insertions were successfully performed in all patients under fluoroscopy. Complications included pain, reflux, and bleeding, which occurred in nine (23.6%), eight (21.1%), and three (8%) patients in Group A, and in 27 (42.9%), eight (12.7%), and 10 (15.9%) patients in Group B, respectively. The stent was retained approximately 4-7 days and was retrieved via endoscope. TSS, esophageal manometry, and barium esophagram post-treatment significantly improved compared to those given pretreatment (P < 0.0001). At the end of follow up, TSS and LES pressure in Group B were 4.00 +/- 1.00 and 43.67 +/- 12.66 mmHg, compared to 10.20 +/- 0.45 (P = 0.0096) and 58.60 +/- 8.65 mmHg (P = 0.1687) in Group A. The Kaplan-Meier method revealed better symptom remission in Group B compared to Group A (log-rank test, P = 0.0212).
Retrievable stent placement is more effective than the same diameter pneumatic dilation for the treatment of achalasia with a long-term follow up.
通过长期随访,回顾性分析比较同直径临时支架置入与气囊扩张治疗贲门失弛缓症的临床疗效。
共纳入 101 例贲门失弛缓症患者,分为气囊扩张组(A 组,n = 38)和临时支架置入组(B 组,n = 63)。气囊或支架直径均为 30mm。采用总症状评分(TSS)和食管测压评估症状和食管下括约肌(LES)压力改善情况。钡餐食管研究客观评估食管排空情况。在定期随访中评估、记录和比较 TSS 和 LES 压力改善情况。
所有患者均在透视下成功完成 49 次气囊扩张和 65 次支架置入。并发症包括疼痛、反流和出血,A 组分别有 9 例(23.6%)、8 例(21.1%)和 3 例(8%)患者出现,B 组分别有 27 例(42.9%)、8 例(12.7%)和 10 例(15.9%)患者出现。支架留置时间约 4-7 天,通过内镜取出。治疗后 TSS、食管测压和钡餐食管造影均明显优于治疗前(P<0.0001)。随访结束时,B 组 TSS 和 LES 压力分别为 4.00±1.00 和 43.67±12.66mmHg,与 A 组的 10.20±0.45(P=0.0096)和 58.60±8.65mmHg(P=0.1687)相比,差异均有统计学意义。Kaplan-Meier 法显示 B 组症状缓解率优于 A 组(log-rank 检验,P=0.0212)。
在长期随访中,可回收支架置入治疗贲门失弛缓症的效果优于同直径气囊扩张。